Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |